Last time, I gave an update on the SAS Health and Life Sciences Executive Conference that was recently held on our campus here in Cary. Dr. John Halamka, one of our keynote speakers, spent some time discussing the challenges in defining "meaningful use", a term used to qualify an organization’s adoption of health IT for purposes of federal funding. The term is actually undefined in the legislation, and since it is linked to the money, there is a lot of activity now within the industry to better define what this means. A lot of activity.
Continue reading “Will the Real "Meaningful Use" Please Stand Up?”
Last time, I gave an update on the SAS Health and Life Sciences Executive Conference that was recently held on our campus here in Cary. Dr. John Halamka, one of our keynote speakers, spent some time discussing the challenges in defining "meaningful use", a term used to qualify an organization’s adoption of health IT for purposes of federal funding. The term is actually undefined in the legislation, and since it is linked to the money, there is a lot of activity now within the industry to better define what this means. A lot of activity.
Continue reading “Will the Real "Meaningful Use" Please Stand Up?”
